Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry

The term “end stage” has been used to describe hypertrophic cardiomyopathy (HCM) with left ventricular systolic dysfunction (LVSD), defined as occurring when left ventricular ejection fraction is <50%. The prognosis of HCM-LVSD has reportedly been poor, but because of its relative rarity, the nat...

Descripción completa

Detalles Bibliográficos
Autores principales: Marstrand, Peter, Han, Larry, Day, Sharlene M., Olivotto, Iacopo, Ashley, Euan A., Michels, Michelle, Pereira, Alexandre C., Wittekind, Samuel G., Helms, Adam, Saberi, Sara, Jacoby, Daniel, Ware, James S., Colan, Steven D., Semsarian, Christopher, Ingles, Jodie, Lakdawala, Neal K., Ho, Carolyn Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182243/
https://www.ncbi.nlm.nih.gov/pubmed/32228044
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182243/
https://www.ncbi.nlm.nih.gov/pubmed/32228044
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044366

Ejemplares similares